While multiple testing increases efficiency, it also has the disadvantage of increasing the likelihood of false positive results; therefore, if anti-TIF-1γ antibodies are detected by Euroline, we strongly recommend confirming the results using a second validated method, most especially in the absence of a definitive DM diagnosis. Here, TRIM33 is linked to dermatomyositis.